[PDF][PDF] Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

J Duraiswamy, R Turrini, A Minasyan, D Barras… - Cancer Cell, 2021 - cell.com
J Duraiswamy, R Turrini, A Minasyan, D Barras, I Crespo, AJ Grimm, J Casado, R Genolet…
Cancer Cell, 2021cell.com
The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and
responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we
show that tumor-specific CD8+ TIL accumulate in tumor islets, where they engage antigen
and upregulate PD-1, which restrains their functions. Intraepithelial PD-1+ CD8+ TIL can be,
however, polyfunctional. PD-1+ TIL indeed exhibit a continuum of exhaustion states, with
variable levels of CD28 costimulation, which is provided by antigen-presenting cells (APC) …
Summary
The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we show that tumor-specific CD8+ TIL accumulate in tumor islets, where they engage antigen and upregulate PD-1, which restrains their functions. Intraepithelial PD-1+CD8+ TIL can be, however, polyfunctional. PD-1+ TIL indeed exhibit a continuum of exhaustion states, with variable levels of CD28 costimulation, which is provided by antigen-presenting cells (APC) in intraepithelial tumor myeloid niches. CD28 costimulation is associated with improved effector fitness of exhausted CD8+ TIL and is required for their activation upon PD-1 blockade, which also requires tumor myeloid APC. Exhausted TIL lacking proper CD28 costimulation in situ fail to respond to PD-1 blockade, and their response may be rescued by local CTLA-4 blockade and tumor APC stimulation via CD40L.
cell.com